Utilizing multiple mouse models, we confirmed that SRSF10 ablation with a selective inhibitor 1C8 robustly inhibits GC growth and enhances CD8<sup>+</sup> T-cell infiltration via CCL2-mediated reprogramming of tumor-associated macrophages (TAMs). This evidence concerns the gene CCL2 and neoplasm.